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There are several three-dimensional (3D) skeletal muscle (SkM) tissue engineered
models reported in the literature. 3D SkM tissue engineering (TE) aims to recapitulate
the structure and function of native (in vivo) tissue, within an in vitro environment.
This requires the differentiation of myoblasts into aligned multinucleated myotubes
surrounded by a biologically representative extracellular matrix (ECM). In the present
work, a new commercially available 3D SkM TE culture chamber manufactured
from polyether ether ketone (PEEK) that facilitates suitable development of these
myotubes is presented. To assess the outcomes of the myotubes within these
constructs, morphological, gene expression, and ECM remodeling parameters were
compared against a previously published custom-built model. No significant differences
were observed in the morphological and gene expression measures between the
newly introduced and the established construct configuration, suggesting biological
reproducibility irrespective of manufacturing process. However, TE SkM fabricated
using the commercially available PEEK chambers displayed reduced variability in both
construct attachment and matrix deformation, likely due to increased reproducibility
within the manufacturing process. The mechanical differences between systems may
also have contributed to such differences, however, investigation of these variables
was beyond the scope of the investigation. Though more expensive than the custom-
built models, these PEEK chambers are also suitable for multiple use after autoclaving.
As such this would support its use over the previously published handmade culture
chamber system, particularly when seeking to develop higher-throughput systems or
when experimental cost is not a factor.
Keywords: skeletal muscle, tissue engineering, C2C12, myotubes, commercially available muscle chamber,
custom-built muscle chamber
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INTRODUCTION
Tissue engineered (TE) three-dimensional (3D) constructs allow
for complex representation of several tissue types in vitro,
including skeletal muscle (SkM). The goal of 3D SkM TE is to
emulate native muscle (Ostrovidov et al., 2014; Perniconi and
Coletti, 2014; Khodabukus and Baar, 2015), which includes the
geometrical, topographical, and physical features of the targeted
tissue (Mohanty et al., 2015). Native SkM tissue consists of
parallel arrays of multinucleated myofibers of relatively equal
size (Bian and Bursac, 2008; Riboldi et al., 2008; Gillies and
Lieber, 2011) that are surrounded by an extracellular matrix
(ECM; Gillies and Lieber, 2011). Therefore, a requirement of SkM
TE is the development of uniaxially aligned myotubes, typically
achieved utilizing a high cell density of muscle precursor cells,
seeded on or within a scaffold anchored between two secured
fixed points (Sakar et al., 2012).
Several published TE 3D SkM models have been reported
in the literature, for example, cylindrical (Okano and Matsuda,
1998; Vandenburgh et al., 2008), mandrel/cylindrical (Okano
and Matsuda, 1997), tubular (Huang et al., 2005; Khodabukus
and Baar, 2009; Martin et al., 2015), and rectangular/cuboidal
systems have been previously demonstrated (Eastwood et al.,
1996; Cheema et al., 2003, 2005; Mudera et al., 2010; Smith
et al., 2012; Hodgson, 2015; key features summarized in Table 1).
Whilst these models (regardless of geometry or size) represent
simplified versions of the desired complex tissue, 3D SkM
constructs have been shown to be capable of supporting cell
growth and maturation (Cen et al., 2008; Bian and Bursac,
2009), force production (Powell et al., 2002; Ito et al., 2014), and
supporting co-culture with organotypic cell types such as motor
neurons (Morimoto et al., 2013; Martin et al., 2015; Smith et al.,
2016).
These 3D TE SkM models are typically cultured within
chambers, which are fabricated using bespoke techniques
and/or custom designs. As such, a large number of models
exist (Vandenburgh et al., 1996, 2008; Dennis and Kosnik,
2000; Powell et al., 2002; Cheema et al., 2003, 2005; Chiron
et al., 2012; Snyman et al., 2013; to list a few, summarized in
Table 1). Thus, manufacturing reproducible chambers can be
problematic, often resulting in experimental variation. In the
present study, TE SkM constructs were fabricated in a precision
manufactured and commercially available polyether ether ketone
(PEEK) 3D SkM TE culture chamber, and were compared to
an 8-well 3D SkM TE culture chamber (8WC) model based on
the attachment of the constructs to handmade “floatation bars”
(Smith et al., 2012). Both SkM configurations have a similar
rectangular geometry, but have variations in cellular volumes,
chamber design, as well as the modes of attachment for the SkM
construct (Figure 1). These variations enable the investigation
of myotube parameters in contrasting systems, similar to those
presented in the literature. Furthermore, by utilizing a precision
manufactured and commercially available system such as the
proposed PEEK chamber, it is foreseen that repeatability and
replication of SkM constructs should be improved above the
custom-built platform. Moreover, adopting an approach utilizing
precision manufacturing would also facilitate movement toward
scalable, higher-throughput systems. When seeking to evaluate
the success of a given model, it is important to consider a
number of myogenic parameters. Thus, it is necessary to examine
the expression of key myogenic genes and the morphological
characteristics of the seeded cells to assess the extent of
differentiation. To this end, the purpose of this study was to
understand the differences in basic myotube, myogenic mRNA
and ECM characteristics when C2C12 myoblasts were cultured
in a previously published custom handmade system (8WC)
compared with a precision manufactured configuration (PEEK).
MATERIALS AND METHODS
Cell Culture
C2C12 myoblasts (Public Health England sourced from ATCC)
at passages 3–12 were maintained in basal Dulbecco’s Modified
Eagle’s Medium (DMEM) (Sigma-Aldrich, United Kingdom)
supplemented with 20% v/v fetal calf serum [First Link (UK) Ltd.,
United Kingdom] and 1% v/v penicillin–streptomycin (Gibco
Life Technologies, United Kingdom). All cell cultures were kept
in a humidified incubator at 37◦C and 5% CO2 for the duration
of the experiment.
Chamber Configurations
Constructs cultured in the 8WC (Figure 1) are setup in
commercially available treated tissue culture plates (NuncTM,
Thermo Fisher Scientific, United Kingdom), with the addition
of polydimethylsiloxane (PDMS, Dow Corning, United States)
walls to divide the chamber to the required dimensions for
the polymerization process. The construct’s attachment/anchor
points are created from the attachment of three small rectangular
layers of polyethylene mesh (Darice Inc., United States) stitched
together by stainless steel wire 0.3 mm (Scientific Wire Company,
United Kingdom). To generate a suitable anchor 0.5 mm hooped
wire was bent over the edge of the side of the well. This
meshed wire structure is known as the a-frame. The chamber
dimensions are 14 mm × 30 mm × 10 mm and the volumetric
capacity is 1.5 mL. Manufactured chambers are fabricated from
PEEK, a plastic that is biocompatible for use with cell cultures
(Panayotov et al., 2016). The custom manufactured chamber
has in-built cylindrical attachment/anchor points, that are posts
set within the wells (Figure 1). The chamber dimensions are
10 mm× 21.5 mm× 5 mm, and the volumetric capacity is 0.5 mL
(Table 2). The PEEK chambers are precision machined, with final
chamber geometries etched into the plastic, and are based on an
outline similar to the CAD design in Figure 1C – PEEK. These
PEEK chambers were designed to be used within standard 6-well
plates. The PEEK chambers were kindly donated by Dr. James
Phillips (University College London, United Kingdom).
Cell Seeded Collagen Skeletal Muscle
Constructs
Type 1 rat tail collagen hydrogels were polymerized as previously
described (Smith et al., 2012). The seeded collagen hydrogels
were made to a measure of: 85% v/v type 1 rat tail collagen
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TABLE 1 | A comparison of commonly published skeletal muscle models.
Publication
features
Vandenburgh et al.,
1996
Okano and
Matsuda, 1998
Vandenburgh
et al., 2008
Chiron et al., 2012 Smith et al., 2012 Martin et al., 2015
Features of published skeletal muscle chambers
Attachment/fixed
points
Velcro and
stainless-steel pins
Fixed points Flexible silicone
posts
Silicone pins Polyethylene mesh Stainless-steel pins
Construct volume 400 µL n/a 100 µL 150 µL 3200 µL 700 µL
Matrix Collagen and
matrigel R©
Collagen Collagen, atrigel R©
and fibrin
Fibrin Collagen Thrombin and fibrin
Matrices type Natural
Seeded cell type C2C12 mouse
myoblasts
C2C12 mouse
myoblasts
Primary mouse
myoblasts
Primary HDMCs Primary rat DMCs C2C12 mouse
myoblasts or primary
human DMCs
Geometric
configuration of
chamber
Rectangular Mandrel – ring
shaped
Cylindrical Rectangular Rectangular Circular – then rolled
cylindrical tubes
Chamber design
type
Custom-built Custom-built Manufactured Custom-built Custom-built Custom-built
Chamber/well type Commercially
available silicone
tubing
Agarose gel ring Custom-built wells
with posts
Custom-built Commercially
available singular
rectangular wells
Custom-built wells
with pins
The chambers used for 3D TE have three main corresponding features. (1) They are anchored by fixed point(s). (2) They have a geometric configuration that is rectangular.
(3) The chambers are used with a natural (compliant) matrix. The hydrogel matrix/scaffold used for supporting cells varies between the models, as does construct volume,
cell type, and seeding density per milliliter (latter not displayed).
[2.05 mg/mL; First Link (UK) Ltd., United Kingdom], 10% of
10× minimal essential media (MEM; Gibco, United Kingdom),
5% v/v growth media (GM) containing C2C12s at cellular density
of 4 × 106 cells/mL. Prior to the addition of cells, the collagen-
MEM solution was neutralized by the drop-wise addition of
sodium hydroxide (NaOH; Sigma-Aldrich, United Kingdom)
at 5 and 1 M aqueous concentrations. Neutralized acellular
collagen solution remained on ice before and after the addition
of C2C12s. The homogeneous mixed seeded constructs (0.5 mL
for PEEK chambers and 1.5 mL for 8WC model, respectively)
were cast into the appropriate chambers and placed in a
humidified incubator at 37◦C and 5% CO2 for 15 min, to allow
polymerization. Following polymerization, 6 mL of GM were
added to each construct before returning to the incubator. GM
was replenished daily, for a period of 4 days, at which point the
medium was removed and replaced with differentiation medium
(DM) consisting of DMEM supplemented with 2% v/v horse
serum (Sigma-Aldrich, United Kingdom) and 1% v/v penicillin–
streptomycin (Gibco, United Kingdom). DM was replaced daily
for the remaining 10 days of culture. Three replicates were created
for each construct and six independent experimental repeats were
conducted with a total “n” number of constructs being 18 per
chamber type; 12 for histochemistry and 6 for gene expression
analysis.
Fluorescent Staining
Following 14 days in culture, the medium was removed from
the wells of both configurations and constructs were fixed using
4% paraformaldehyde for a minimum of 60 min. Subsequently,
constructs were cut away from the attachment mesh and
fixed points and washed three times with 1× Tris-buffered
saline (TBS). Constructs were then submersed in 300 µL of
0.2% v/v Triton X-100 (Fisher Scientific, United Kingdom)
and diluted in TBS for 120 min. Following three further
washes with TBS, constructs were incubated overnight with
rhodamine-phalloidin (Life Technologies, United Kingdom)
diluted 1:200 v/v in TBS. The following day, constructs were
washed three times with TBS prior to incubation with 300 µL
of 4′,6-diamidino-2-phenylindole (DAPI; Life Technologies,
United Kingdom) diluted 1:2000 v/v in TBS for 10 min. Following
a final three washes with TBS, constructs were placed on
polylysine-coated microscope slides (VWR, United Kingdom)
and mounted to a coverslip using FluoromountTM (Sigma-
Aldrich, United Kingdom) mounting medium.
Microscopic and Macroscopic Images
Images of fluorescently stained TE SkM constructs were obtained
using a confocal microscope (Zeiss LSM 880, Carl Zeiss,
Germany) (Figure 2). Sets of 60 images were taken of myotubes
within the constructs of each chamber type. Macroscopic
images of whole constructs within their chambers (to assess
macroscopic contraction) were taken throughout the duration of
the experiment (Figure 2B). Images captured were taken using
a digital camera (PEEK only) or a flatbed scanner (Epson V370)
(8WC only).
Image Analysis of Seeded Collagen
Skeletal Muscle Construct
All images (micro and macroscopic) were analyzed using FIJI
Software by Image J (NIH, Bethesda, MD, United States)
to collate the data for the different parameters required for
the assessment of the two configurations. The following list
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FIGURE 1 | Muscle chambers. (A) Schematic illustration of the muscle chambers with their respective attachment points. (B) CAD model of the respective
chambers (images A and B are not to scale). (C) The 8WC and PEEK chambers used in our experimental research. The images have been enhanced by outlining
the constructs to define their contrast within their chamber against the surrounding medium. Scale bars = 10 mm.
TABLE 2 | Comparison of the chamber features used in this investigation to
generate tissue engineered skeletal muscle.
8-Well chamber PEEK chamber
Muscle chamber features
Attachment/fixed points Polyethylene mesh
attachment
PEEK pins
Seeding conditions Both 4 × 106 cells/mL of collagen used
Construct volume (mL) 1.5 0.5
Geometric configuration Rectangular Rectangular
Design type Custom-built Commercially available –
precision manufactured
Well type Tissue culture plastic –
rectangular 8-well
PEEK wells with posts
Chamber cost £4.37 per chamber £99.60 per chamber
(autoclavable)
of measurements were obtained for each image: myotube
width, myotube length, fusion index, number of myotubes, cell
density, and the number of nuclei per myotube. Myotubes
were classified as elongated structures containing three or more
nuclei within a single membrane structure. Irregular mass,
clumps, or multi-branched aggregation conformations (complex
dysmorphic myotubes) with three or more nuclei were not
counted as myotubes. Most myotubes were aligned to the
uniaxial isometric lines of strain within the gel, however, some
singular branched dysmorphic myotubes were counted. Myotube
diameter was calculated as the average of 10 measurements along
the myotube length (Rommel et al., 2001; Agley et al., 2012)
for a representative measure. The fusion index was calculated as
the number of nuclei incorporated into myotubes expressed as
a percentage of the total number of nuclei in the image frame
(Martin et al., 2015).
RNA Extraction and RT-qPCR
3D TE SkM constructs for both chamber types were detached
from their anchor points and transferred to sterile 1.5 mL
microcentrifuge tubes containing 500 µL of TRI Reagent
(Sigma-Aldrich, United Kingdom). The homogenization process
(maximal shear) was achieved using a needle (23/21G) and
syringe technique. RNA extraction was conducted according
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FIGURE 2 | Construct deformation (percentage of construct surface area reduction) over time (a maximum of 14 days) and percentage of attachment failure.
(A) Construct deformation shows the area of construct reduction over the course of the experiment at key intervals (0, 4, 7, and 14 days). The dotted lines with an
asterisk show the link between the time intervals that have significance (p-value < 0.05) within the chamber type. The dotted line with a triangle (p-value < 0.0001)
across the chamber types. (B) Macroscopic images of the constructs at days 0, 4, 7, and 14 showing the constructs deformation over the course of the
experimental time frame. The upper images are of PEEK constructs that have been enhanced by outlining the constructs to define their contrast within their chamber
against the surrounding medium. The lower row images are of the 8WC. Scale bar = 10 mm. (C) Attachment failure shows that 8WC has the highest construct
failure for both complete and semi-failure, and the image inserts depict attachment failures. For panel (C) significance at ∗P < 0.05, ∗∗∗P = 0.0002, ∗∗∗∗P < 0.0001.
to the TRI reagent manufacturer’s instructions (Sigma-
Aldrich, United Kingdom) using chloroform, 2-propanol
and 70% v/v ethanol reagents (grade 200-proof, Sigma-Aldrich,
United Kingdom). RNA quality and quantity were measured by
a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific,
United Kingdom). Real-time quantitative polymerase chain
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TABLE 3 | Primer sequences used for detection of differentiation and extra-cellular matrix remodelling mRNA markers.
Gene Forward primer sequence Reverse primer sequence Function
RP2β GGTCAGAAGGGAACTTGTGGTAT GCATCATTAAATGGAGTAGCGTC Housekeeper
Myogenin CCAACTGAGATTGTCTGTC GGTGTTAGCCTTATGTGAAT Differentiation
MMP-2 GAGATCTTCTTCTTCAAGGAC AATAGACCCAGTACTCATTCC Matrix remodeling
MMP-9 CTGGCAGAGGCATACTTG GCCGTAGAGACTGCTTCT Matrix remodeling
reactions (RT-qPCRs) were prepared in triplicate in 348-well
plates, where each well contained 20 ng of RNA diluted in 5 µL
of RNase free water, 0.1 µL of forward and reverse primers
(Sigma-Aldrich, United Kingdom; see Table 3), 0.1 µL of
RT mix (Qiagen, Germany) and 4.7 µL of SYBR green mix
(Qiagen, Germany) to make 10 µL total reaction volumes.
One-step RT-qPCR was performed on a Viia7TM Real-Time
PCR system (Applied Biosystems/Thermo Fisher Scientific,
United Kingdom), which was programed to perform the
following: 10 min at 50◦C (to enable reverse transcription),
5 min at 95◦C (to activate “Hot Start” Taq polymerase), followed
by 40 cycles of 95◦C for 10 s and 60◦C for 30 s. Data was
analyzed using the comparative CT otherwise known as the
Livak method (Schmittgen and Livak, 2008) and relative gene
expression 2(−11CT) method using RP2β as the reference gene.
The muscle markers selected as primers (Table 3) were myogenin
(MYOG) an indicator of myogenic differentiation and matrix
metalloproteinases (MMPs)-2 and -9 as indicators of matrix
remodeling.
Statistical Analysis
All data sets are presented as the mean value± standard deviation
per condition on day 14. Normality tests were conducted to
evaluate the distribution of the data. t-Tests were conducted
for myotube analysis tests and (factorial) two-way ANOVA
for construct deformation; both tests were used to determine
if statistical differences existed between the two different
construct chambers. t-Tests were conducted using GraphPad
Prism software V6 (GraphPad Software Inc., United States).
Factorial ANOVA was conducted using IBM SPSS version
23 (International Business Machines Corp., United States).
Significance was set at an alpha value of p ≤ 0.05.
RESULTS
Construct Deformation and Failure Rates
Construct area reduction (deformation) was measured over the
experimental duration of 14 days (Figure 2). Morphologically,
the percentage area of reduction for the 8WC and PEEK
constructs increased over time (4 days: 28.89 ± 7.55% 8WC vs.
62.88 ± 5.44% PEEK, p-value < 0.0001; 7 days: 30.57 ± 12.17%
8WC vs. 64.86 ± 5.25% PEEK, p-value < 0.0001; 14 days:
47.87± 10.70% 8WC vs. 69.39± 5.50% PEEK, p-value< 0.0001).
This demonstrates, that mean percentage deformation (reduction
in area) is greater in the PEEK than 8WC at all time points
analyzed (excluding day 0). Interestingly, the 8WC constructs
failed to reach 50% deformation by end the end of the experiment,
which may well be a result of differences in construct volume
and total cell number compared to the PEEK system. Figure 2C
highlights the failure rates for both 8WC and PEEK constructs.
It was noticed that PEEK constructs only failed within the first
24 h due to failed attachment to the posts. Complete failure
(total detachment from anchor posts) and partial detachment
was more frequent for the 8WC than for the PEEK, suggesting
collagen attachment and remodeling is different between systems.
Complete and semi-failure rates, reported significant differences
between chamber types (Figure 2, semi-failure: 50.21 ± 23.74%
8WC vs. 0% PEEK, p < 0.0001, complete failure: 24.2 ± 8.44%
8WC vs. 4.20 ± 4.60% PEEK, p = 0.05). This large variability in
failure rates highlights the difficulty in reliability and handling of
the custom-built chamber and its construct, respectively.
Morphological Parameters of C2C12
Myotubes Within 3D Tissue-Engineered
Constructs in Different Chamber
Configurations
To determine the overall level of morphological differentiation
(and variable differences), myotube parameters (myotube; width,
length, number, number of nuclei per myotube, and fusion
index) were measured based on fluorescence imaging of the
actin cytoskeleton (Figure 3). This allowed a detailed comparison
between both systems to be made (Table 4). Myotube parameters
for the 8WC model were found to be generally higher (increases
in mean values), compared to the PEEK chamber. However,
no statistical differences were noted for any measures (all
p > 0.05), indicating that the morphological outcomes were
reproducible between both chamber types. This suggests that
FIGURE 3 | C2C12 myotubes within collagen matrix of 3D tissue-engineered
constructs. Confocal images at 14 days. Histochemical staining with
rhodamine-phalloidin (actin filaments in red). Cells nuclei are counterstained
with 4′,6-diamidino-2-phenylindole (DAPI; nuclei in blue). (A) PEEK constructs
and (B) 8-well constructs. Scale bars at 50 µm.
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TABLE 4 | Parameters used to assess morphological difference after 14 days in
culture.
8-Well chamber PEEK chamber p-values
Morphological measures
Myotube width (µm) 14.32 ± 2.10 14.00 ± 2.75 0.9949
Myotube length∗ (µm) 172.10 ± 18.35 165.9 ± 11.82 0.9672
Number of myotubes
(au)
25.00 ± 8.74 21.17 ± 8.23 0.8109
Number of nuclei per
myotube (au)
6.818 ± 1.32 8.770 ± 2.03 0.1000
Cell density (au) 139.0 ± 26.45 124.6 ± 28.34 0.6611
Fusion index (%) 45.93 ± 6.94 52.87 ± 2.96 >0.9999
Distance between
myotubes (µm)
14.47 ± 5.55 8.63 ± 2.58 0.414
Number of myotube
branches (au)
3.17 ± 1.83 2.32 ± 1.47 0.261
Mean measures of the myotube parameters and their units from their respective
constructs (chamber type). Au, arbitrary units. ∗Due to limitation of the image frame
myotube length measurements are possibly greater than that measured.
despite differences in volumes, dimensions, and anchor types
between chamber types, the degree to which myotubes form at
a given seeding density may be limited.
mRNA Expression Levels for
Differentiation and Remodeling Matrix
Markers at Day 14
Myogenic gene expression markers are indicators which can
be used to gain insight into the progress of these early SkM
cells (myoblasts) toward cellular differentiation (Bentzinger et al.,
2012). Levels of mRNA expression for differentiation (MYOG)
and ECM remodeling markers (MMP-2 and -9), were compared
between the PEEK chamber and 8WC (Figure 4). There were no
significant differences between the two chambers for all genes
measured, with similar p-values (all p > 0.99), supporting the
morphological outcomes described above, and a trend toward
biological reproducibility within the model irrespective of tissue
chamber manufacturing method.
DISCUSSION
TE of 3D SkM is based on the developmental biology and
regeneration of native tissue, i.e., the ability of myogenic
precursors to activate, proliferate, and differentiate into
multinucleated myotubes in 3D (Okano and Matsuda, 1997,
1998; Okano et al., 1997). Consequently, many SkM models
(Table 1) display three common features: (i) high cellular
density (Khodabukus et al., 2007; Mudera et al., 2010); (ii) the
ECM/scaffold used (Bian and Bursac, 2008, 2009); and (iii) the
presence of fixed points within the chamber facilitating uniaxial
(isometric) tension enabling cellular alignment (Table 1).
Despite these commonalities, the bespoke nature of these
published models means there are many differences in the basic
configuration; shape, volume, attachment type, etc.
Here, a comparison between two contrasting systems was
made in order to determine differences in myotube parameters.
Assessment of fluorescence micrographs of the PEEK chamber
vs. 8WC, clearly shows similar myotube morphology, with
singular unbranched myotubes regardless of the configuration
used (Table 4). This response confirms previous publication by
this research group, in larger scale models using the similar
chamber materials (5 and 3 mL; Sharples et al., 2012; Smith et al.,
2012; Player et al., 2014).
Myogenin has been extensively reported to be a late marker of
myoblast fusion, required for terminal differentiation (Tan et al.,
2015). Mudera et al. (2010) and Smith et al. (2012) demonstrated
the expression pattern of MYOG in similar tissue engineered
models, where comparisons were made against 2D controls. It
was suggested that myotube formation was supported by the
extent of MYOG expression (Mudera et al., 2010; Smith et al.,
2012), which supports the results reported herein. The expression
of MYOG mRNA, showed no difference between configurations
tested, suggesting the molecular regulation of differentiation is
not altered between conditions.
The similarity in myotube formation also highlights the
importance of isometric and uniaxial strain providing ECM
cues for directional signaling, independent of anchor type
and attachment structure. Cellular attachment, alignment, and
ECM remodeling contributes to macroscopic characteristic
deformation (Sharples et al., 2012; Smith et al., 2012), causing
loss of interstitial fluid (Phillips, 2014). Subsequently, an increase
in relative cell density contributes to an increase in cell–cell
contact promoting fusion. Despite this, clear differences in
construct deformation were found between chamber types. This
data contrasts previous observations of ECM remodeling gene
expression, where no differences were observed in either MMP-2
or -9 mRNA, which may reflect the post-translational function
FIGURE 4 | mRNA expression levels for differentiation and remodeling matrix markers. Gene expression at day 14 for (A) MYOG, (B) MMP-2, and (C) MMP-9. No
significance difference (n.s.), p-values all measured >0.99.
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of these proteins. Indeed, it may well be that within a given
configuration (where finite mechanical signals are different) there
is a limit in the extent to which matrix remodeling contributes
to myotube formation and may also reflect differences at
macroscopic and molecular levels.
Attachment failure in both its forms (complete and semi)
was more prevalent in the 8WC compared to the PEEK. An
overview of the morphological parameters of the constructs from
both chamber types, also shows that the PEEK constructs have
reduced variability (standard deviation) than 8WC constructs
(number of nuclei per myotube, being the exception). Indeed,
variability within custom made systems has previously been
noted in engineered muscle (Brady et al., 2008; Mudera et al.,
2010) and therefore the present results indicate that a precision
manufactured PEEK system could lead to improved and more
standardized results.
The custom, handmade 8WC produces variation and
inconsistencies, both in assembly between researchers and
positioning within the chamber. As such, it is likely that this will
have a marked effect as to how the constructs attach and develop.
By utilizing a commercially available PEEK chamber, consistency
and reliability are achieved with this system, particularly as the
chambers can be autoclaved and reused. This consistency and
reliability becomes more critical when using primary cells types
which are difficult to derive, isolate, and culture. Furthermore,
this precision manufacturing facilitates the use of automation
techniques, which will be a key asset for applications requiring
higher-throughput (Vandenburgh, 2010; Nam et al., 2015).
CONCLUSION
In this study, 3D TE SkM constructs were fabricated using
both commercially available PEEK and custom-built 8WC.
Engineered muscle fabricated using PEEK and 8WC were
comparable in myotube morphology and mRNA expression,
however, the collagen matrix in PEEK constructs deformed
and remodeled faster than in the 8WC setup. Importantly,
however, the variables measured showed less variability in PEEK
configurations compared to 8WC, and displayed dramatically
reduced experimental failure rates. The PEEK chamber offers a
consistent and reliable system to engineer SkM, however, with
no apparent differences in the myotubes that are produced, the
resource and particularly the application should be considered
when selecting chamber type.
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